Hero Banner

CARDIOLOGY

Session Topic

short description short description short description short description short description short description short description

SPEAKER NAME and Credentials

CARDIOLOGY

Session Topic

short description short description short description short description short description short description short description

SPEAKER NAME and Credentials

CARDIOLOGY

Session Topic

short description short description short description short description short description short description short description

SPEAKER NAME and Credentials

CARDIOLOGY

Session Topic

short description short description short description short description short description short description short description

SPEAKER NAME and Credentials

DON’T MISS THESE TOPICS AND MORE!

Agenda
Friday, May 19, 2023
Lifestyle, Diet, Physical Activity and Inflammation
8:00 AM — 8:05 AM
Welcome and Introduction
Robert H. Eckel, MD
8:05 AM — 8:25 AM
Nutrition, inflammation and cardiometabolic disease
Pam R. Taub, MD, FACC, FASPC
8:25 AM — 8:45 AM
Physical activity and impact on chronic inflammation and cardiometabolic health: exploring the links & evidence
Carl J. Lavie, MD, FACC
8:45 AM — 9:05 AM
Stress management, sleep & recovery
Virend Somers, MD, PhD
9:05 AM — 9:25 AM
Genetic Testing for Early Hypertension, Dyslipidemia, DM and CHD
Mark C. Houston, MD, MS, FACP, ABAARM
9:25 AM — 9:45 AM
Transition of NAFLD to NASH: inflammation is the culprit
Stephen A. Harrison, MD
9:45 AM — 10:30 AM
Expert Panel Discussion and Q & A
Moderator: Robert H. Eckel, MD
Panelists: Stephen A. Harrison, MD; Mark C. Houston, MD, MS, FACP, ABAARM; Carl J. Lavie, MD, FACC; Virend Somers, MD, PhD; Pam R. Taub, MD, FACC, FASPC
10:30 AM — 11:00 AM
Break
11:00 AM — 12:00 PM
PME Lunch Symposium (Non-CME)
Circadian bromocriptine-QR therapy attenuates elevated sympathetic tone, postprandial dysmetabolism, and an immune proinflammatory state and reduces adverse cardiovascular event rate: Clinical studies summary in T2DM subjects
Sponsored by VeroScience.
Anthony H. Cincotta, PhD
12:00 PM – 1:00 PM
Break & Exhibit Hall
Cardiovascular Disease
1:00 PM
Introductions
Christie M. Ballantyne, MD
1:00 PM – 1:40 PM
Keynote Address: Inflammation and immunity in aging and atherothrombosis
Peter Libby, MD
1:40 PM – 2:20 PM
Inflammation and atherosclerosis: current and future approaches for clinical interventions
Paul M. Ridker, MD, MPH
2:20 PM – 2:50 PM
The impact of inflammation in heart failure: prevention, testing, and treatment
Ileana Piña, MD, MPH
2:50 PM – 3:20 PM
Links between systemic inflammation and cardiovascular disease: focus on cardio-rheumatology
Brittany N. Weber, MD, PhD
3:20 PM – 4:00 PM
Expert Panel Discussion and Q & A
Moderator: Christie M. Ballantyne, MD
Panelists: Peter Libby, MD; Pamela B. Morris, MD; Ileana Piña, MD, MPH; Paul M. Ridker, MD, MPH; Brittany N. Weber, MD, PhD
4:00 PM – 6:00 PM
Break & Exhibit Hall
Saturday, May 20, 2023
Hypertension, Lipids, and Obesity
8:00 AM — 8:05 AM
Day 2 Opening Remarks
Pamela B. Morris, MD
8:05 AM — 8:25 AM
Inflammation and hypertension: novel mechanistic insights
George L. Bakris, MD
8:25 AM — 8:50 AM
Lipoproteins and Inflammation – Focus on LDL, Lp(a) and TG rich lipoproteins and new therapies in development
Christie M. Ballantyne, MD
8:50 AM — 9:15 AM
Obesity, Inflammation and Cardiovascular Risk
Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
9:15 AM — 10:00 AM
Expert Panel Discussion and Q & A
Moderator: Pamela B. Morris, MD
Panelists: Christie M. Ballantyne, MD; George L. Bakris, MD; Robert H. Eckel, MD; Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
10:00 AM – 11:00 AM
Break
11:00 AM – 12:00 PM
PME Lunch Symposium (Non-CME)
A Treatment Option for Patients with Heart Failure
Sponsored by AstraZeneca.
Victor N. Howard, MD, FACC
12:00 PM – 1:00 PM
Break & Exhibit Hall
Type 2 Diabetes and Kidney Disease
1:00 PM
Introductions
Robert H. Eckel, MD
1:00 PM – 1:25 PM
Is there a role of inflammation in type 2 diabetes pathogenesis?
Sam Dagogo-Jack, MD, DSc
1:25 PM – 1:50 PM
CKD, T2DM and inflammation: pathogenesis and more
Jennifer Green, MD
1:50 PM – 2:15 PM
Prevention, screening and treatment of chronic kidney disease
Rajiv Agarwal, MD
2:15 PM – 3:00 PM
Expert Panel Discussion and Q & A
Moderator: Robert H. Eckel, MD
Panelists: Jennifer Green, MD; Rajiv Agarwal, MD; Sam Dagogo-Jack, MD, DSc
3:00 PM – 4:30 PM
Break & Exhibit Hall
Register Now!

2023 CMHC Spring Registration

$195.00

Gaylord Palms Resort & Convention Center in Orlando

Rate: $379

Deadline: January 16, 2023

Phone: 888-879-0462
(Mention Cardiometabolic Health Congress to get our group rate)

PROSPECTUS

VIEW EXHIBITOR PROSPECTUS  

FAQ's

Here are some common questions we’ll answer NOW, the rest you can ask the experts this May 19-20, 2023, in Orlando!

A: Low-grade systemic inflammation precedes the onset of cardiovascular events by many years, and inflammation is a consistent predictor of cardiovascular risk.

A: A large body of clinical data shows that reducing inflammation has cardiometabolic benefits, and reducing inflammation remains an active area of research that also has important clinical implications, including in the prevention and management of obesity, dyslipidemia, heart failure, chronic kidney disease, hypertension, and type 2 diabetes.

A: An excess of macronutrients in the adipose tissues stimulates inflammatory mediators such as tumor necrosis factor α and interleukin 6; it also reduces the production of adiponectin, promoting inflammation and oxidative stress.

A: Inflammation is a primary mechanism in developed cardiometabolic diseases including coagulation, atherosclerosis, metabolic syndrome, insulin resistance and type 2 diabetes. It is also associated with the development of diseases such as psoriasis, depression, cancer, and renal diseases, conditions that often occur comorbidly in people with cardiometabolic conditions.

A: The activation of nuclear factor kappa B (NF-κB) links pathogenic and cellular danger signals, organizing cellular resistance to perceived threats and triggering inflammation.